ESSA Pharma Inc.
EPIX
$1.74
$0.021.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.53M | -6.36M | -7.23M | -8.99M | -5.96M |
| Total Depreciation and Amortization | 23.40K | 22.80K | 22.70K | 22.20K | 23.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.44M | 2.68M | 2.08M | 1.20M | 191.00K |
| Change in Net Operating Assets | -399.40K | 290.10K | -618.80K | 946.60K | -1.04M |
| Cash from Operations | -6.47M | -3.37M | -5.75M | -6.82M | -6.79M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.93M | 21.02M | 23.50K | 62.51M | 8.23M |
| Cash from Investing | -3.93M | 21.02M | 23.50K | 62.51M | 8.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 59.70K | 25.60K | 643.60K | 196.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 59.70K | 25.60K | 643.60K | 196.70K |
| Foreign Exchange rate Adjustments | -- | 6.50K | -1.90K | 4.10K | 400.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.40M | 17.72M | -5.70M | 56.34M | 1.64M |